Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Nina Mallmann-Gottschalk"'
Autor:
Cheng Pei, Plamen Todorov, Qingduo Kong, Mengyang Cao, Evgenia Isachenko, Gohar Rahimi, Frank Nawroth, Nina Mallmann-Gottschalk, Wensheng Liu, Volodimir Isachenko
Publikováno v:
Cells, Vol 13, Iss 18, p 1539 (2024)
Background: Earlier studies have established that culturing human ovarian tissue in a 3D system with a small amount of soluble Matrigel (a basement membrane protein) for 7 days in vitro increased gene fusion and alternative splicing events, cellular
Externí odkaz:
https://doaj.org/article/77311bbf8e3843bfbede758cf517e18f
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/4609f53de0444934ace64d0a0cc10c40
Immunoglobulins and serum proteins impair anti-tumor NK cell effector functions in malignant ascites
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionMalignant ascites indicates ovarian cancer progression and predicts poor clinical outcome. Various ascites components induce an immunosuppressive crosstalk between tumor and immune cells, which is poorly understood. In our previous study,
Externí odkaz:
https://doaj.org/article/fb001130642741d6af7e684fe2f83b55
Autor:
Antonio Hrvat, Mathias Schmidt, Bernd Wagner, Denise Zwanziger, Rainer Kimmig, Lothar Volbracht, Sven Brandau, Nina Mallmann-Gottschalk
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 42, Iss 1, Pp 1-19 (2023)
Abstract Background Malignant ascites commonly occurs in advanced or recurrent stages of epithelial ovarian cancer during peritoneal carcinomatosis and is correlated with poor prognosis. Due to its complex composition of cellular and acellular compon
Externí odkaz:
https://doaj.org/article/e35492f228ef4d518541830ae82afb79
Autor:
Antonio Hrvat, Mathias Schmidt, Martin Obholzer, Sonja Benders, Sebastian Kollenda, Peter A. Horn, Matthias Epple, Sven Brandau, Nina Mallmann-Gottschalk
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Calcium phosphate nanoparticles (CaP-NPs) are biodegradable carriers that can be functionalized with biologically active molecules. As such, they are potential candidates for delivery of therapeutic molecules in cancer therapies. In this context, it
Externí odkaz:
https://doaj.org/article/c9a5bf293f554bd58601bd49bbb32de0
Autor:
Marit Ahrens, Salah-Eddin Al-Batran, Robert Armbrust, Séverine Banek, Sven Becker, Lothar Bergmann, Jörg Bojunga, Tim Henrik Brümmendorf, Uta Brunnberg, Gesine Bug, Michael Burger, Jörg Chromik, Felix K.-H. Chun, Carolin Czauderna, Franz Ludwig Dumoulin, Martin Dreyling, Ahmed El-Balat, Jörg Ellinger, Susanne Elsner, Julius C. Enßle, Christian Fottner, Peter R. Galle, Nicola Gökbuget, Thorsten Oliver Götze, Teresa Halbsguth, Benedikt Höh, Peter Hohenberger, Joachim Hübner, Jutta Hübner, Susanne Isfort, Bernd Kasper, Alexander Katalinic, Angelika Kestler, Yascha Khodamoradi, Johannes Kleemann, Luis A. Kluth, Viktoria F. Köhler, Otto Kollmar, Steffen Koschmieder, Fabian Lang, Philipp Makowka, Peter Mallmann, Nina Mallmann-Gottschalk, Philipp Mandel, Gabriele Maurer, Arnulf Mayer, Markus Meissner, Franka Menge, Jan Moritz Middeke, Wolfgang Miesbach, Markus Möhler, Volker Möbus, Stefan C. Müller, Thomas J. Musholt, Friedemann Nauck, Thomas Oellerich, Deniz Özistanbullu, Rainer Porschen, Christian Pox, Konrad Klaus Richter, Tilman Sauerbruch, Sebastian Scheich, Johannes Schetelig, Heinz Schmidberger, Hans-Georg Schnürch, Martin Sebastian, Jalid Sehouli, Ulf Seifart, Hubert Serve, Thomas Seufferlein, Shabnam Shaid, Savas D. Soysal, Björn Steffen, Joachim P. Steinbach, Jan A. Stratmann, Ioannis Tsoukakis, Evelyn Ullrich, Janne Vehreschild, Ivana von Metzler, Michael von Wolff, Martin Voß, Sebastian Wagner, Matthias M. Weber, Henning Wege, Joachim Weis, Maria-Noemi Welte, Mike Wenzel, Timo Wolf, David Zurmeyer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62fd2826b690ce9d97fc5e64e445eb5e
https://doi.org/10.1016/b978-3-437-23824-6.00069-9
https://doi.org/10.1016/b978-3-437-23824-6.00069-9
Autor:
Kristyna Nemejcova, Roman Kocian, Christhardt Kohler, Jiri Jarkovsky, Jaroslav Klat, Alberto Berjon, Radovan Pilka, Borek Sehnal, Blanca Gil-Ibanez, Ezequiel Lupo, Almerinda Petiz, Octavio Arencibia Sanchez, Peter Kascak, Fabio Martinelli, Alessandro Buda, Jiri Presl, Marc Barahona, Luc van Lonkhuijzen, Wiktor Szatkowski, Lubos Minar, Maja Pakiz, Pavel Havelka, Cristina Zorrero, Marcin Misiek, Leon Cornelius Snyman, Dariusz Wydra, Ignace Vergote, Alla Vinnytska, Mikulas Redecha, Martin Michal, Solveig Tingulstad, Barbara Kipp, Grzegorz Szewczyk, Robert Toth, Francisco Javier de Santiago Garcia, Pluvio Jesus Coronado Martin, Robert Poka, Karl Tamussino, Mathieu Luyckx, Maxime Fastrez, Juan Carlos Staringer, Anna Germanova, Andrea Plaikner, Sylva Bajsova, Pavel Dundr, Nina Mallmann-Gottschalk, David Cibula
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Cancers, 12(5):1115. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, Vol. 12, no. 5, p. 1115 [1-13] (2020)
Cancers
Volume 12
Issue 5
Cancers, Vol 12, Iss 1115, p 1115 (2020)
Universidad de Barcelona
Cancers, 12(5):1115. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, Vol. 12, no. 5, p. 1115 [1-13] (2020)
Cancers
Volume 12
Issue 5
Cancers, Vol 12, Iss 1115, p 1115 (2020)
The quality of pathological assessment is crucial for the safety of patients with cervical cancer if pelvic lymph node dissection is to be replaced by sentinel lymph node (SLN) biopsy. Central pathology review of SLN pathological ultrastaging was con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::0f61c5981537a3d11c475dd4c02d1e56
http://hdl.handle.net/2445/171944
http://hdl.handle.net/2445/171944
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 20, Iss 19, p 4693 (2019)
Volume 20
Issue 19
International Journal of Molecular Sciences, Vol 20, Iss 19, p 4693 (2019)
Volume 20
Issue 19
The adverse prognosis of most patients with ovarian cancer is related to recurrent disease caused by resistance to chemotherapeutic and targeted therapeutics. Besides their direct activity against tumor cells, monoclonal antibodies and tyrosine kinas